NYSEARCA:INNO - NYSE Arca - US41151J3077 - ETF - Currency: USD
This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry transformation.
Innocan Pharma's Q1 2024 revenue surged 334% to $6.8M, driven by strong sales growth from BI Sky Global. Read about financial performance.
Mentions: AMZN
Pre-market stock movers are a great way to start the week as we check out all of the biggest news moving shares on Monday!